Literature DB >> 11564213

Establishment and characterization of cell line TNMY1 derived from human malignant fibrous histiocytoma.

T Nakatani1, T Marui, T Yamamoto, M Kurosaka, T Akisue, K Matsumoto.   

Abstract

Although malignant fibrous histiocytoma (MFH) is one of the most common soft tissue sarcomas, its pathogenesis remains unclear. In this study, a cell line derived from human MFH, TNMY1, was established from a metastatic chest-wall lesion of a 60-year-old woman with MFH. The TNMY1 cell line was passaged 95 times, and it still retained the biological characteristics of the original tumor. TNMY1 consists of spindle-shaped cells and pleomorphic cells associated with multinucleated giant cells. Immunohistochemical studies showed that the spindle-shaped and pleomorphic cells were positive for vimentin, CD68 and alpha-smooth muscle actin, but negative for epithelial membrane antigen, desmin, muscle actin, alpha-sarcomeric actin, myoglobin, lysozyme and S-100 protein. The cells expressed collagen types I, III and V. These results indicate that MFH may originate from mesenchymal stem cells with the potential to differentiate into either fibroblasts or histiocytes. An elevated level of collagen type V mRNA expression is considered to support a diagnosis of MFH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564213     DOI: 10.1046/j.1440-1827.2001.01253.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  6 in total

1.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

2.  Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.

Authors:  Marc Becker; Claudine Graf; Marcus Tonak; Markus P Radsak; Tobias Bopp; Robert Bals; Rainer M Bohle; Matthias Theobald; Pol-Maria Rommens; Dirk Proschek; Thomas C Wehler
Journal:  Oncol Lett       Date:  2016-06-24       Impact factor: 2.967

3.  Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.

Authors:  Tsunenari Maeda; Susumu Hashitani; Yusuke Zushi; Emi Segawa; Noriaki Tanaka; Kazunari Sakurai; Masahiro Urade
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-04       Impact factor: 4.553

4.  Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

Authors:  Rosario Gil-Benso; Javier Megías; Teresa San-Miguel; Sandra Pinto; Robert C Callaghan; Concha López-Ginés; Miguel Cerdá-Nicolás
Journal:  Cytotechnology       Date:  2017-07-04       Impact factor: 2.058

5.  Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.

Authors:  Masaya Minoda; Teruya Kawamoto; Takeshi Ueha; Etsuko Kamata; Masayuki Morishita; Risa Harada; Mitsunori Toda; Yasuo Onishi; Hitomi Hara; Masahiro Kurosaka; Toshihiro Akisue
Journal:  Int J Oncol       Date:  2015-07-09       Impact factor: 5.884

6.  'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.

Authors:  Mitsunori Toda; Teruya Kawamoto; Takeshi Ueha; Kenta Kishimoto; Hitomi Hara; Naomasa Fukase; Yasuo Onishi; Risa Harada; Masaya Minoda; Masahiro Kurosaka; Toshihiro Akisue
Journal:  Int J Oncol       Date:  2013-06-28       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.